COMMUNIQUÉS West-GlobeNewswire

Lexicon Pharmaceuticals Announces Poster Presentation at ASCO GI
02/01/2018
THE WOODLANDS, Texas, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]
Atara Biotherapeutics Announces Proposed Offering of Common Stock
02/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
Mesa Labs Declares Quarterly Dividend
02/01/2018
Lakewood, CO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB ) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0. [...]
Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP
02/01/2018
NORTHVALE, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Transactions concluded by management
02/01/2018
Olaine, 2018-01-02 16:47 CET (GLOBE NEWSWIRE) -- AS Olainfarm has received the notification of manager on transactions with securities issued by AS Olainfarm. The received notification is available in attachment. [...]
American Health Council’s Honors Charles Tucker DNP, MSN, RN, CNE as “Best in Nursing”
02/01/2018
NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- The American Health Council honors accomplished clinician and Associate Professor of Nursing Charles Tucker DNP, MSN, RN, CNE as one of America’s “Best in Nursing.” Dr. Tucker [...]
Hemispherx Biopharma CEO Discusses 2017 Highlights on CEOLIVE.TV
02/01/2018
ORLANDO, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), based in Orlando, FL, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive [...]
AIT Therapeutics Appoints Yoori Lee to its Board of Directors
02/01/2018
Seasoned veteran with decades of strategic, scientific, clinical and leadership experience NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused [...]
Genmab to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
Media Release Copenhagen, Denmark; January 2, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 36 th Annual J.P. Morgan Healthcare [...]
Coherus BioSciences Management to Present at The 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
REDWOOD CITY, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that senior management will present at the 36 th annual J.P. Morgan healthcare conference on Monday, [...]
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
02/01/2018
SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D [...]
Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors
02/01/2018
SALT LAKE CITY, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), announces the appointment of Michael Dey, Ph.D. to the Board of Directors of Predictive Technology Group, Inc. Dr. Dey [...]
Progenics Pharmaceuticals Completes Enrollment in Phase 3 Study of PSMA-Targeted Imaging Agent 1404
02/01/2018
NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, today [...]
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
02/01/2018
SEATTLE, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that it received a product-specific pediatric waiver from the European [...]
Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
BriaCell To Attend Biotech Showcase™ 2018
02/01/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
02/01/2018
WALTHAM, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS ) announced today that Elhan Webb has joined the Company as Head of Investor Relations and External [...]
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
02/01/2018
TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company committed to improving patient lives by manufacturing and delivering high quality biologics, [...]
Selecta Biosciences Announces FDA Acceptance of Investigational New Drug Application for LMB-100 and SVP-Rapamycin Combination Therapy
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]

Pages